Alterity Therapeutics (ATHE.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Nov10

Alterity Therapeutics Presents Favorable Data on ATH434 for Orthostatic Hypotension and MSA

12:26

Oct14

Jason McCarthy Issues Buy Rating on Alterity Therapeutics Stock

18:56

Sep29

Alterity Therapeutics Predicts ATH434 Global Peak Sales of $2.4 Billion

05:01

Aug29

Alterity Therapeutics released FY2025 earnings on August 28 (EST), actual revenue USD 3.526 M (forecast USD 3.591 M), actual EPS USD -0.7386 (forecast USD -0.82)

03:00

Alterity Therapeutics released FY2025 9 Months Earnings on August 28 (EST), actual revenue USD 2.259 M, actual EPS USD -0.6765

03:00

Alterity Therapeutics released FY2025 Q3 earnings on August 28 (EST), with actual revenue of USD 1.205 M and EPS of USD -0.1252

03:00

Schedules & Filings

Schedules

Filings

Aug28

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 1.25 M, Net Income -1.623 M, EPS -0.1299

Feb28

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 499.51 K, Net Income -2.231 M, EPS -0.2612

Aug29

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 706.56 K, Net Income -4.208 M, EPS -0.5262

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change